University of California, Los Angeles: Schizophrenia trials
The registry lists 27 Schizophrenia studies with University of California, Los Angeles as lead sponsor. 3 are open to participants now and 10 have results posted.
Phase 1 1Phase 2 4Phase 4 10No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Inter-Brain Synchrony in SchizophreniaRecruitingNCT07177261Not applicable
- Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia EpisodeRecruitingNCT05890183Not applicable
- Low-dose Buprenorphine as a Modulator of Social Motivation in SchizophreniaRecruitingNCT05778591Phase 2
- Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia EpisodeTerminatedNCT04203056Phase 4Results posted
- Improving Cognition in Schizophrenia Using tDCSCompletedNCT02539797Not applicableResults posted
- Target Engagement for Oxytocin: Dose Ranging StudyCompletedNCT02498236Not applicableResults posted
- Modafinil Effects on Cognition in Schizophrenia PatientsCompletedNCT00711464Phase 4Results posted
- A Multicenter Study of NAP (AL-108) in SchizophreniaCompletedNCT00505765Phase 2Results posted
- Treatment Study for Cognitive Deficits in SchizophreniaCompletedNCT00505076Phase 2Results posted
- Modafinil for Treatment of Cognitive Dysfunction in SchizophreniaCompletedNCT00423943Phase 4Results posted
- Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset SchizophreniaCompletedNCT00333177Phase 4Results posted
- Oral Versus Injectable Risperidone for Treating First-Episode SchizophreniaCompletedNCT00330551Phase 4Results posted
- Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia PatientsCompletedNCT00183625Phase 4Results posted
- An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive SymptomsWithdrawnNCT05956600Not applicable
- Feasibility Trial of a Lifestyle Intervention for CHR-PCompletedNCT05532683Not applicable
- Target Engagement and Response to OxytocinCompletedNCT03245437Phase 4
- Enhancing Cognitive Training Through Exercise Following a First Schizophrenia EpisodeCompletedNCT02823041Not applicable
- Glutamate, Learning, and Working MemoryCompletedNCT02769936Phase 1
- Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteineCompletedNCT02505477Phase 4
- Enhancing Cognitive Training Through Exercise After a First Schizophrenia EpisodeCompletedNCT02267070Not applicable
- A System for Preference Assessment in Mental HealthCompletedNCT02183844Not applicable
- Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode SchizophreniaCompletedNCT01451736Phase 4
- Web-Based Weight Management for Individuals With Mental IllnessCompletedNCT01324973Not applicable
- Promoting Adherence to Treatment in SchizophreniaCompletedNCT01125267Not applicable
- Org 24448 (Ampakine) for Cognitive Deficits in SchizophreniaWithdrawnNCT00425815Phase 2
- Improving Work Outcome in People With Recent-onset SchizophreniaCompletedNCT00203788Phase 4
- Online Family Support and Education for SchizophreniaCompletedNCT00046085Not applicable